Qiagen N.V.
NYSE:QGEN · New York Stock Exchange
-$0.35 today
Vol 1.44M · Avg 2.07M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-16.44%
Period High
$55.66
Period Low
$32.63
Latest
$36.95
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Exelixis, Inc.
NASDAQ:EXEL
$13.26B
Align Technology, Inc.
NASDAQ:ALGN
$12.55B
ICON Public Limited Company
NASDAQ:ICLR
$11.08B
Revvity, Inc.
NYSE:RVTY
$10.98B
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
$10.71B
Baxter International Inc.
NYSE:BAX
$10.14B
The Ensign Group, Inc.
NASDAQ:ENSG
$9.08B
Charles River Laboratories International, Inc.
NYSE:CRL
$8.85B
Bio-Techne Corporation
NASDAQ:TECH
$8.64B
Hims & Hers Health, Inc.
NYSE:HIMS
$7.31B
What is the latest QGEN filing?
The latest filing shown is SC 13G/A dated Jun 5, 2026.
How many recent filings does QGEN have?
Intrinsic Alpha currently shows 20 recent filings for QGEN.
Explore More
Continue the stock analysis
Jump to another research area for this company.